CIK 0001868279
- Non-accelerated filer
- Emerging growth company
ArriVent BioPharma, Inc.
Sign in to watch- Ticker
- AVBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 240-780-6356
- Business address
- 18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +16,265 | $3.65 | $59K | 152,001 |
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +410 | $2.28 | $935 | 152,411 |
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +4,550 | $2.28 | $10K | 156,961 |
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +1,820 | $2.28 | $4K | 158,781 |
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +17,648 | $6.24 | $110K | 176,429 |
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −410 | 0 | ||
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −4,550 | 1,820 | ||
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −1,820 | 0 | ||
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −16,265 | 2,600 | ||
| 2026-10-30 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −17,648 | 38,823 | ||
| 2026-02-02 | LaChapelle Robin Chief Operating Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2025-07-11 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +2,050 | $2.28 | $5K | 126,633 |
| 2025-07-11 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +2,600 | $2.28 | $6K | 129,233 |
| 2025-07-11 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +6,503 | $2.28 | $15K | 135,736 |
| 2025-07-11 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −2,050 | 410 | ||
| 2025-07-11 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −2,600 | 12,873 | ||
| 2025-07-11 | LaChapelle Robin Chief Operating Officer | Exercise or conversion · Stock Option (right to buy) | −6,503 | 6,370 | ||
| 2025-02-03 | LaChapelle Robin Chief Operating Officer | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | ||
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +2,700 | $6.24 | $17K | 99,717 |
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Exercise or conversion | +2,867 | $2.28 | $7K | 102,584 |
Page 1 of 2 · 28 trades